Hormone replacement therapy in the prevention and treatment of atherosclerosis (Q34107469)

31 July 2017

1 reference

title

Hormone replacement therapy in the prevention and treatment of atherosclerosis (English)

1 reference

Hormone Replacement Therapy

31 July 2017

1 reference

1 reference

Mosca L

1

1 reference

31 July 2017

1 July 2000

1 reference

Current Atherosclerosis Reports

31 July 2017

1 reference

31 July 2017

2

1 reference

31 July 2017

4

1 reference

31 July 2017

297-302

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-000-0062-8

31 July 2017

0 references

cites work

Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0062-8

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0062-8

Subclinical atherosclerosis in relation to hysterectomy status in black women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0062-8

Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0062-8

A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0062-8

Lipoprotein(a) and Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0062-8

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0062-8

Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0062-8

Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0062-8

Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0062-8

Hormone replacement therapy and circulating ICAM-1 in postmenopausal women--a randomised controlled trial

21 January 2018

1 reference

12 December 2020

Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells

1 reference

12 December 2020

Estrogen regulates low density lipoprotein metabolism by cultured swine granulosa cells.

1 reference

12 December 2020

Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women

1 reference

12 December 2020

Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery

1 reference

12 December 2020

Influence of age and menopause on serum lipids and lipoproteins in healthy women.

1 reference

12 December 2020

17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males.

1 reference

12 December 2020

Regression of atherosclerosis in female monkeys

1 reference

12 December 2020

The pathophysiology of atherosclerosis

1 reference

12 December 2020

Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activity

1 reference

12 December 2020

The protective effects of estrogen on the cardiovascular system

1 reference

12 December 2020

Hormone replacement therapy, heart disease, and other considerations

1 reference

12 December 2020

High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel

1 reference

12 December 2020

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 reference

12 December 2020

Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients

1 reference

12 December 2020

Ovarian ablation alone promotes aortic intimal hyperplasia and accumulation of fibroblast growth factor

1 reference

12 December 2020

Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women's Heart Disease and Stroke Campaign Task Force

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

1 reference

12 December 2020

Oral 17 beta-estradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal women.

1 reference

12 December 2020

Vascular smooth muscle cells possess estrogen receptor and respond to estrogen

1 reference

12 December 2020

Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women.

1 reference

12 December 2020

Triglycerides and coronary risk in women and the elderly

1 reference

12 December 2020

Estrogen replacement reverses endothelial dysfunction in postmenopausal women

1 reference

12 December 2020

Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms.

1 reference

12 December 2020

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

1 reference

12 December 2020

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial

1 reference

12 December 2020

Primary endothelial dysfunction: atherosclerosis

1 reference

12 December 2020

Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Effects of 17beta-estradiol and progesterone on the adhesion of human monocytic THP-1 cells to human female endothelial cells exposed to minimally oxidized LDL.

1 reference

12 December 2020

Impaired ovarian function and risk factors for atherosclerosis in premenopausal women

1 reference

12 December 2020

The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables

1 reference

12 December 2020

Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women

1 reference

12 December 2020

No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) Study Investigators

1 reference

12 December 2020

Menopause and risk factors for coronary heart disease

1 reference

12 December 2020

Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women

1 reference

12 December 2020

Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone

1 reference

12 December 2020

Cholesterol, cholesterol lowering, and endothelial function

1 reference

12 December 2020

Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression

1 reference

12 December 2020

Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells.

1 reference

12 December 2020

Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits

1 reference

12 December 2020

Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations

1 reference

12 December 2020

Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes

1 reference

12 December 2020

Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. I. Relation between fibrin and immobilization of apo B-containing lipoprotein

1 reference

12 December 2020

Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease

1 reference

12 December 2020

Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions

1 reference

12 December 2020

Cholesterol lowering and endothelial function

1 reference

12 December 2020

HERS--a missed opportunity

1 reference

12 December 2020

Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function

1 reference

12 December 2020

Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop

1 reference

12 December 2020

Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease.

1 reference

12 December 2020

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis

1 reference

12 December 2020

Estrogen and atherosclerosis

1 reference

12 December 2020

Changes in plasma lipids and lipoproteins associated with starting or stopping postmenopausal hormone replacement therapy

1 reference

12 December 2020

Lipoprotein (a) and coronary heart disease.

1 reference

12 December 2020

Postmenopausal hormone therapy and mortality.

1 reference

12 December 2020

Hormone replacement therapy in postmenopausal women: carotid intima-media thickness and 3-D volumetric plaque quantification

1 reference

12 December 2020

The effect of hormone replacement therapy on carotid arteries: measurement with a high frequency ultrasound system

1 reference

12 December 2020

Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis

1 reference

12 December 2020

Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women

1 reference

12 December 2020

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

1 reference

12 December 2020

Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate

1 reference

12 December 2020

Coagulation activation following estrogen administration to postmenopausal women

1 reference

12 December 2020

10.1007/S11883-000-0062-8

Identifiers

DOI

1 reference

PubMed ID

11122757

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11122757